What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
Authors
Keywords
-
Journal
World Psychiatry
Volume 17, Issue 2, Pages 149-160
Publisher
Wiley
Online
2018-06-01
DOI
10.1002/wps.20516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention
- (2018) Delbert G. Robinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic Disorders
- (2017) Jose M. Rubio et al. JOURNAL OF CLINICAL PSYCHIATRY
- Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use
- (2017) Maren Carbon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Accuracy of Clinician Assessments of Medication Status in the Emergency Setting
- (2017) Leonardo V. Lopez et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice
- (2017) Yusuke Nakata et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Randomized controlled trial of deutetrabenazine for tardive dyskinesia
- (2017) Hubert H. Fernandez et al. NEUROLOGY
- A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia
- (2017) Martin Harrow et al. PSYCHIATRY RESEARCH
- Stability and development of psychotic symptoms and the use of antipsychotic medication – long-term follow-up
- (2017) D. R. Gotfredsen et al. PSYCHOLOGICAL MEDICINE
- The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum
- (2017) S. Guloksuz et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis
- (2017) J. Vermeulen et al. PSYCHOLOGICAL MEDICINE
- Reduced Thickness of the Anterior Cingulate Cortex in Individuals With an At-Risk Mental State Who Later Develop Psychosis
- (2017) Yoichiro Takayanagi et al. SCHIZOPHRENIA BULLETIN
- Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis
- (2017) Toby T Winton-Brown et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis
- (2017) Regitze Sølling Wils et al. SCHIZOPHRENIA RESEARCH
- A critique of the “ultra-high risk” and “transition” paradigm
- (2017) Jim van Os et al. World Psychiatry
- Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas
- (2017) Nancy H. Liu et al. World Psychiatry
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
- (2017) Christoph U. Correll et al. World Psychiatry
- Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis
- (2017) Davy Vancampfort et al. World Psychiatry
- Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia
- (2017) Stefan P. Brugger et al. JAMA Psychiatry
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
- (2017) Jari Tiihonen et al. JAMA Psychiatry
- Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial
- (2017) Ane Storch Jakobsen et al. PLoS One
- Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment
- (2016) Deepak K. Sarpal et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study
- (2016) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project
- (2016) Ricardo E. Carrión et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
- (2016) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders
- (2016) Cherrie Galletly et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries
- (2016) Brendon Stubbs et al. BMC Medicine
- Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
- (2016) Robin M. Murray et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
- (2016) John Yin et al. Current Neuropharmacology
- Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics
- (2016) Fuminari Misawa et al. SCHIZOPHRENIA RESEARCH
- Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis
- (2016) Hiroshi Yamanaka et al. SCHIZOPHRENIA RESEARCH
- The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
- (2016) Helene Speyer et al. World Psychiatry
- Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
- (2016) Davy Vancampfort et al. World Psychiatry
- Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia
- (2015) Wenjing Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies
- (2015) Antonio Vita et al. BIOLOGICAL PSYCHIATRY
- Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China
- (2015) Mao-Sheng Ran et al. BRITISH JOURNAL OF PSYCHIATRY
- Excess mortality in severe mental illness: 10-year population-based cohort study in rural Ethiopia
- (2015) Abebaw Fekadu et al. BRITISH JOURNAL OF PSYCHIATRY
- Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics
- (2015) Erica A. Voss et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals
- (2015) Jacqueline Mayoral-van Son et al. JOURNAL OF CLINICAL PSYCHIATRY
- Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium
- (2015) T G M van Erp et al. MOLECULAR PSYCHIATRY
- Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment
- (2015) Mohamed Ahmed et al. NEUROPSYCHOPHARMACOLOGY
- The neuropathology of schizophrenia: A selective review of past studies and emerging themes in brain structure and cytoarchitecture
- (2015) K. Bakhshi et al. NEUROSCIENCE
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
- (2015) Christoph U. Correll et al. World Psychiatry
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Does long term use of psychiatric drugs cause more harm than good?
- (2015) P. C. Gotzsche et al. BMJ-British Medical Journal
- Antipsychotic Maintenance Treatment: Time to Rethink?
- (2015) Joanna Moncrieff PLOS MEDICINE
- Does long term use of psychiatric drugs cause more harm than good?
- (2015) P. C. Gotzsche et al. BMJ-British Medical Journal
- Premature Mortality Among Adults With Schizophrenia in the United States
- (2015) Mark Olfson et al. JAMA Psychiatry
- A Multimodal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia
- (2015) Tyler A. Lesh et al. JAMA Psychiatry
- Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia
- (2015) Deepak K. Sarpal et al. JAMA Psychiatry
- Schizophrenia
- (2015) René S. Kahn et al. Nature Reviews Disease Primers
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial
- (2014) Anthony P Morrison et al. LANCET
- Clinically meaningful biomarkers for psychosis: A systematic and quantitative review
- (2014) Diana Prata et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cognitive-Behavioral Therapy for Medication-Resistant Psychosis: A Meta-Analytic Review
- (2014) Amy M. N. Burns et al. PSYCHIATRIC SERVICES
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic Treatment and Mortality in Schizophrenia
- (2014) M. Torniainen et al. SCHIZOPHRENIA BULLETIN
- Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia — An observational 9-year follow-up study
- (2014) Anja P. Husa et al. SCHIZOPHRENIA RESEARCH
- A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis
- (2014) Hiroshi Kimura et al. SCHIZOPHRENIA RESEARCH
- Relapse Duration, Treatment Intensity, and Brain Tissue Loss in Schizophrenia: A Prospective Longitudinal MRI Study
- (2013) Nancy C. Andreasen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
- (2013) Casey Crump et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes
- (2013) Thomas R. E. Barnes et al. BRITISH JOURNAL OF PSYCHIATRY
- Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry
- (2013) John M. Kane et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia
- (2013) Taishiro Kishimoto et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia
- (2013) Jennifer A Hadley et al. NEUROPSYCHOPHARMACOLOGY
- Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
- (2013) P. Fusar-Poli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Laterality interacts with sex across the schizophrenia/bipolarity continuum: An interpretation of meta-analyses of structural MRI
- (2013) Timothy J. Crow et al. PSYCHIATRY RESEARCH
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
- (2013) Davy Vancampfort et al. World Psychiatry
- Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
- (2013) John M. Kane et al. World Psychiatry
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
- (2012) M. Lahti et al. PSYCHOLOGICAL MEDICINE
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
- (2012) T. Kishimoto et al. SCHIZOPHRENIA BULLETIN
- A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
- (2012) E. Jaaskelainen et al. SCHIZOPHRENIA BULLETIN
- Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects
- (2012) Sander V. Haijma et al. SCHIZOPHRENIA BULLETIN
- Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies
- (2012) M. Alvarez-Jimenez et al. SCHIZOPHRENIA RESEARCH
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials
- (2012) Jacqueline Caemmerer et al. SCHIZOPHRENIA RESEARCH
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Long-term Antipsychotic Treatment and Brain Volumes
- (2011) Beng-Choon Ho et al. ARCHIVES OF GENERAL PSYCHIATRY
- Quantifying Clinical Relevance in the Treatment of Schizophrenia
- (2011) Christoph U. Correll et al. CLINICAL THERAPEUTICS
- Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern Finland 1966 Birth Cohort study
- (2011) J. Moilanen et al. EUROPEAN PSYCHIATRY
- Brain Volume Changes After Withdrawal of Atypical Antipsychotics in Patients With First-Episode Schizophrenia
- (2011) Geartsje Boonstra et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
- (2011) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- D2Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
- (2010) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effect of Antipsychotic Medication Alone vs Combined With Psychosocial Intervention on Outcomes of Early-Stage Schizophrenia
- (2010) Xiaofeng Guo et al. ARCHIVES OF GENERAL PSYCHIATRY
- Longitudinal Volume Reductions in People at High Genetic Risk of Schizophrenia as They Develop Psychosis
- (2010) Andrew M. McIntosh et al. BIOLOGICAL PSYCHIATRY
- Apparent Cerebral Atrophy in Patients on Treatment with Steroids
- (2010) Neil Gordon DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization
- (2010) Beryl Koener et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
- (2010) Diego Novick et al. PSYCHIATRY RESEARCH
- Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials
- (2009) Virginia Stauffer et al. BMC Psychiatry
- Differences in mortality and suicidal behaviour between treated and never-treated people with schizophrenia in rural China
- (2009) Mao-Sheng Ran et al. BRITISH JOURNAL OF PSYCHIATRY
- A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
- (2009) Hiroyuki Uchida et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
- (2009) L. B. Dixon et al. SCHIZOPHRENIA BULLETIN
- Gray Matter in First-Episode Schizophrenia Before and After Antipsychotic Drug Treatment. Anatomical Likelihood Estimation Meta-analyses With Sample Size Weighting
- (2009) M. Leung et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions
- (2008) P R Bakker et al. MOLECULAR PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now